参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/20 | 1,659 | 1,670 | 1,634 | 1,637 | -13 | -0.8% | 530,800 |
2019/05/17 | 1,631 | 1,654 | 1,615 | 1,650 | +32 | +2% | 1,087,500 |
2019/05/16 | 1,620 | 1,630 | 1,598 | 1,618 | +6 | +0.4% | 709,500 |
2019/05/15 | 1,612 | 1,620 | 1,588 | 1,612 | -29 | -1.8% | 1,064,700 |
2019/05/14 | 1,596 | 1,650 | 1,594 | 1,641 | +5 | +0.3% | 909,300 |
2019/05/13 | 1,674 | 1,674 | 1,636 | 1,636 | -25 | -1.5% | 1,089,500 |
2019/05/10 | 1,670 | 1,724 | 1,651 | 1,661 | -34 | -2% | 1,980,800 |
2019/05/09 | 1,740 | 1,740 | 1,680 | 1,695 | -37 | -2.1% | 1,198,000 |
2019/05/08 | 1,747 | 1,749 | 1,725 | 1,732 | -42 | -2.4% | 1,319,700 |
2019/05/07 | 1,693 | 1,776 | 1,690 | 1,774 | +80 | +4.7% | 2,278,800 |
2019/04/26 | 1,692 | 1,698 | 1,676 | 1,694 | -2 | -0.1% | 681,500 |
2019/04/25 | 1,672 | 1,707 | 1,669 | 1,696 | +16 | +1% | 1,077,600 |
2019/04/24 | 1,690 | 1,709 | 1,678 | 1,680 | +26 | +1.6% | 1,331,500 |
2019/04/23 | 1,671 | 1,678 | 1,654 | 1,654 | -14 | -0.8% | 992,100 |
2019/04/22 | 1,650 | 1,672 | 1,638 | 1,668 | +14 | +0.8% | 539,400 |
2019/04/19 | 1,650 | 1,663 | 1,648 | 1,654 | +28 | +1.7% | 957,300 |
2019/04/18 | 1,663 | 1,666 | 1,624 | 1,626 | -57 | -3.4% | 1,514,900 |
2019/04/17 | 1,659 | 1,684 | 1,657 | 1,683 | +23 | +1.4% | 824,000 |
2019/04/16 | 1,662 | 1,677 | 1,652 | 1,660 | +8 | +0.5% | 965,000 |
2019/04/15 | 1,655 | 1,665 | 1,642 | 1,652 | +32 | +2% | 1,124,800 |
2019/04/12 | 1,633 | 1,633 | 1,597 | 1,620 | -32 | -1.9% | 1,388,800 |
2019/04/11 | 1,631 | 1,670 | 1,628 | 1,652 | +36 | +2.2% | 1,401,500 |
2019/04/10 | 1,606 | 1,623 | 1,603 | 1,616 | -7 | -0.4% | 629,100 |
2019/04/09 | 1,628 | 1,628 | 1,609 | 1,623 | -12 | -0.7% | 739,400 |
2019/04/08 | 1,636 | 1,648 | 1,622 | 1,635 | +11 | +0.7% | 797,700 |
2019/04/05 | 1,629 | 1,644 | 1,620 | 1,624 | -19 | -1.2% | 1,292,700 |
2019/04/04 | 1,662 | 1,665 | 1,635 | 1,643 | -34 | -2% | 1,146,100 |
2019/04/03 | 1,669 | 1,680 | 1,647 | 1,677 | +8 | +0.5% | 951,400 |
2019/04/02 | 1,700 | 1,700 | 1,669 | 1,669 | -8 | -0.5% | 742,100 |
2019/04/01 | 1,685 | 1,693 | 1,667 | 1,677 | +28 | +1.7% | 1,059,700 |
2019/03/29 | 1,653 | 1,669 | 1,649 | 1,649 | +15 | +0.9% | 1,020,500 |
2019/03/28 | 1,655 | 1,667 | 1,620 | 1,634 | -38 | -2.3% | 907,700 |
2019/03/27 | 1,663 | 1,685 | 1,661 | 1,672 | +8 | +0.5% | 1,295,600 |
2019/03/26 | 1,608 | 1,670 | 1,603 | 1,664 | +67 | +4.2% | 1,776,800 |
2019/03/25 | 1,594 | 1,605 | 1,582 | 1,597 | -27 | -1.7% | 1,320,200 |
2019/03/22 | 1,627 | 1,630 | 1,610 | 1,624 | -16 | -1% | 1,478,200 |
2019/03/20 | 1,649 | 1,651 | 1,615 | 1,640 | -13 | -0.8% | 1,444,600 |
2019/03/19 | 1,672 | 1,672 | 1,648 | 1,653 | -32 | -1.9% | 906,100 |
2019/03/18 | 1,688 | 1,688 | 1,670 | 1,685 | +9 | +0.5% | 1,167,700 |
2019/03/15 | 1,656 | 1,693 | 1,653 | 1,676 | +22 | +1.3% | 1,961,100 |
2019/03/14 | 1,688 | 1,699 | 1,654 | 1,654 | -18 | -1.1% | 1,390,900 |
2019/03/13 | 1,692 | 1,703 | 1,664 | 1,672 | -24 | -1.4% | 1,055,900 |
2019/03/12 | 1,675 | 1,709 | 1,671 | 1,696 | +44 | +2.7% | 1,860,700 |
2019/03/11 | 1,674 | 1,681 | 1,647 | 1,652 | -22 | -1.3% | 1,651,500 |
2019/03/08 | 1,700 | 1,709 | 1,668 | 1,674 | -56 | -3.2% | 2,132,800 |
2019/03/07 | 1,728 | 1,737 | 1,718 | 1,730 | -16 | -0.9% | 1,891,900 |
2019/03/06 | 1,760 | 1,765 | 1,737 | 1,746 | +15 | +0.9% | 2,323,500 |
2019/03/05 | 1,727 | 1,738 | 1,713 | 1,731 | -26 | -1.5% | 2,340,400 |
2019/03/04 | 1,774 | 1,790 | 1,752 | 1,757 | -13 | -0.7% | 2,373,300 |
2019/03/01 | 1,735 | 1,775 | 1,734 | 1,770 | +35 | +2% | 1,944,800 |
1351~
1400
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
市場注目の銘柄
チャート関連のコラム